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1  | INTRODUC TION
Globally, infertility remains a prevalent and escalating health con­
dition with the male factor contributing partially or wholly to ap­
proximately half of the infertile couples (Inhorn & Patrizio, 2015), of 
which oxidative stress (OS) is a major contributor. OS is defined as 
an excessive amount of reactive oxygen species (ROS) as compared 
to the available amount of seminal antioxidants (Agarwal, Panner 
Selvam, et al., 2019; Henkel et al., 2003). Consequently, the physio­
logical mechanisms in maintaining the redox equilibrium, which 
play a crucial role for sperm functions and the fertilisation process 
(Henkel et al., 2003), are totally overwhelmed. As a result, OS may 
lead to male infertility due to the reaction between oxidants and any 
cellular components, hence causing an increased rate of lipid peroxi­
dation, loss of protein function and sperm DNA damage. Currently, it 
is estimated that OS is the causative factor in 30%–80% of the male 
infertility cases (Agarwal, Prabakaran, & Allamaneni, 2006; Iwasaki 
& Gagnon, 1992; Ochsendorf et al., 1994; Shekarriz, Thomas, & 
Agarwal, 1995; Zini, Lamirande, & Gagnon, 1993).
Leucocytes represent a major source of seminal ROS as they are 
thought to produce about 1,000 times more ROS than spermatozoa, 
when they are activated in response to a proper stimulus (Plante, 
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Oxidative stress (OS) is characterised by an excessive amount of reactive oxygen 
species (ROS) which negatively affect sperm functions. In this study, the influence 
of leucocytes on seminal oxidation–reduction potential (ORP) and sperm DNA frag­
mentation (SDF) was investigated in 1,068 men. Seminal leucocyte concentration 
did not correlate with SDF, unadjusted ORP, ORP normalised for sperm concentra­
tion (sORP), ORP normalised for total motile sperm concentration (motORP) or total 
motile	 sperm	count	 (TMSC-ORP).	Although	 receiver	operator	 characteristic	 (ROC)	
curve analyses show that leucocytospermia does not predict high sORP values 
(>1.34 mV/106	 spermatozoa/ml),	 the	motORP	 (AUC:	0.666)	and	TMSC-ORP	 (AUC:	
0.683) predict the rate of leucocytospermia significantly (p = .0195 and p = .0085 re­
spectively).	Moreover,	SDF	can	significantly	predict	leucocytospermia	(AUC:	0.679;	
p	=	 .011)	and	vice	versa	(AUC:	0.657,	p = .0298). Our data confirm the association 
between	OS	and	SDF.	 In	conclusion,	motORP	and	TMSC-ORP	may	be	better	pre­
dictive factors of leucocytospermia, probably because sperm motility, included in 
motORP	and	TMSC-ORP	calculation,	is	the	first	seminal	parameter	to	be	affected	by	
OS. Although all these parameters are indicative of OS, ORP values, SDF and leuco­
cytospermia should be considered independently for the evaluation of redox seminal 
status, as they probe distinct seminal features.
K E Y W O R D S
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Lamirande,	 &	Gagnon,	 1994).	 According	 to	 the	WHO	 guidelines,	
leucocytospermia is defined as a seminal leucocyte concentration 
higher than 1 × 106	white	blood	cells	(WBC)/ml	semen	(WHO,	2010)	
and is associated with inflammatory and infectious conditions, 
as well as lifestyle habits, such as smoking, alcohol and abuse of 
drugs	(Sandoval,	Raburn,	&	Muasher,	2013).	Leucocytospermia	has	
been shown to have a negative effect on sperm parameters (Aziz, 
Agarwal,	 Lewis-Jones,	 Sharma,	 &	 Thomas,	 2004;	 Moskovtsev,	
Willis,	 White,	 &	 Mullen,	 2007;	 Omu,	 Al-Qattan,	 Al-Abdul-Hadi,	
Fatinikun,	&	Fernandes,	1999;	Thomas	et	al.,	1997).
The leucocyte count correlates positively with seminal ROS 
levels, suggesting OS as a mediator for functional sperm ab­
normalities (Henkel et al., 2003). Activated leucocytes, in fact, 
can release much higher amounts of ROS than spermatozoa (de 
Lamirande & Gagnon, 1995; Plante et al., 1994), which explains 
why leucocyte counts, even lower than 1 × 106	 WBC/ml,	 can	
significantly	 impair	 sperm	 motility	 (Thomas	 et	 al.,	 1997),	 mor­
phology (Aghazarian, Stancik, Pflüger, & Lackner, 2013) and chro­
matin integrity (Erenpreiss, Hlevicka, Zalkalns, & Erenpreisa, 2002; 
Mahfouz	et	al.,	2010).
The	MiOXSYS	system	is	a	new	technology	that	determines	semi-
nal OS (Agarwal, Gupta, & Sharma, 2016; Agarwal, Roychoudhury, 
Bjugstad,	&	Cho,	2016;	Agarwal,	Sharma,	Roychoudhury,	Plessis,	
& Sabanegh, 2016). This novel technology determines the bal­
ance between all oxidants and antioxidants by measuring the 
oxidation–reduction potential (ORP) in semen or seminal plasma 
samples (Agarwal, Gupta, et al., 2016; Agarwal, Roychoudhury, 
et al., 2016; Agarwal, Sharma, et al., 2016). The measurement of 
ORP has been identified as a marker for male infertility (Agarwal, 
Henkel, Sharma, Tadros, & Sabanegh, 2018) since higher levels are 
associated with a decrease in sperm concentration and motility 
(Agarwal, Gupta, et al., 2016; Agarwal, Roychoudhury, et al., 2016; 
Agarwal, Sharma, et al., 2016). A cut­off value of 1.34 mV/106 sper­
matozoa/ml has been established to discriminate between fertile 
and infertile men (Agarwal, Panner Selvam, et al., 2019). However, 
the contribution of leucocytes to the seminal equilibrium between 
oxidation and reduction is still unclear.
Therefore, this study aims to investigate the contribution of leu­
cocytes to the seminal ORP and sperm DNA fragmentation (SDF) as 
an OS­related marker.
2  | MATERIAL AND METHODS
2.1 | Study design
This study was conducted on data collected from 1,068 men attend­
ing	the	Male	Fertility	Unit	of	Hamad	Medical	Center,	Doha,	Qatar,	a	
tertiary medical centre, over a period of 6 months (January 2018–
June 2018). Only patients tested for both SDF and ORP were in­
cluded in the study. Patients with azoospermia, testicular malignancy, 
receiving chemotherapy or radiotherapy as well as under treatment 




All samples were tested for conventional semen analysis, presence 
of	 leucocytospermia	 (≥1	 ×	 106	 WBC/ml),	 seminal	 ORP	 and	 SDF.	
Semen samples were collected in the centre or at home by mastur­
bation following 2–4 days of ejaculatory abstinence. Seminal analy­
sis	was	 performed	within	 1	 hour	 of	 collection	 according	 to	WHO	
criteria	post-liquefaction	at	37°C	(WHO,	2010).
2.3 | Quantification of seminal leucocytes
Of the 1,068 samples included in this study, 59 presented at least 
1 × 106 round cells/ml of semen. The Endtz test was used to dis­
criminate peroxidase­positive leucocytes from other round cells and 
quantify	them	as	recommended	by	the	WHO	(2010).	Brown-stained	
peroxidase­positive leucocytes as well as unstained peroxidase­
nega tive cells were counted and expressed as 106 cells/ml. A 
leucocyte	concentration	of	≥1	×	106 cells/ml is classified as leuco­
cytospermia	(Politch,	Wolff,	Hill,	&	Anderson,	1993).
2.4 | Measurement of oxidation–reduction potential 
(ORP)
Oxidation–reduction potential was measured using the galvanostat­
based	 MiOXSYS	 (Aytu	 BioScience;	 Agarwal,	 Gupta,	 et	 al.,	 2016;	
Agarwal, Roychoudhury, et al., 2016; Agarwal, Sharma, et al., 2016). 
In brief, an aliquot of 30 µl of the unprocessed liquefied semen was 
placed on a disposable sensor and inserted into the analyser holder. 
The test results, provided after about 4 min and expressed in mil­
livolt (mV), are a ‘snapshot’ of the current balance between oxidants 
and reductants. These unadjusted ORP values were then normalised 
to sperm concentration (sORP) and the data presented as mV/106 
spermatozoa/ml. A sORP value of 1.34 mV/106 spermatozoa/ml 
was considered as cut­off, with values above or equal to this cut­off 
being regarded as high sORP and those less than the cut­off as low 
sORP (Agarwal, Panner Selvam, et al., 2019; Agarwal, Parekh, et al., 
2019). Additionally, unadjusted ORP has also been normalised for 
the total motile sperm concentration (motORP) and the total motile 
sperm	count	(TMSC-ORP),	expressed	as	mV/106 motile spermato­
zoa/ml and mV/106 motile spermatozoa, respectively.
2.5 | Determination of sperm DNA fragmentation 
(SDF)
Sperm DNA fragmentation was evaluated by means of the sperm 
chromatin dispersion (SCD) assay (Halosperm G2 test kit, Halotech 
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DNA SL) as per manufacturer's instructions. A mixture of equal 
volumes of the semen sample and 6.5% agarose gel was treated 
with	 an	 acid	 solution	 to	 denature	 fragmented	 DNA,	 for	 7	 min	
at room temperature. Subsequently, the samples were treated 
with a lysis solution for 20 min and stained in eosin and thiazine­
based	solutions	(7	min	each).	The	evaluation	was	performed	using	
bright­field microscopy. Intact DNA loops around the agarose­
embedded sperm nucleus form a characteristic ‘halo’ appearance. 
Spermatozoa with fragmented DNA show very small halos or do 
not exhibit any halos. A threshold of 30% was used to distinguish 
between	patients	with	high	 and	normal	 SDF	 (Majzoub,	Agarwal,	
Cho,	&	Esteves,	2017).
2.6 | Statistical analysis
Statistical	 analysis	 was	 performed	 using	 MedCalc	 Statistical	
Software	 version	 v19.0.3	 (MedCalc	 Software	 Ltd.).	 After	 testing	
the data for normal distribution using the chi­squared test, group 
comparisons were performed with respect to quantitative and 
categorical	 variables	 using	 the	 Mann–Whitney	 or	 Fisher's	 exact	
test. Spearman's rank correlation was used to analyse the relation­
ship between the leucocyte concentration, ORP values and SDF. 
Receiver operator characteristic (ROC) analyses were used to de­
termine if ORP values could predict the rate of leucocytospermia. 
The diagnostic value of the presence of leucocytospermia for iden­
tifying high or low sORP and SDF was also assessed. ROC curves 
were described by the following parameters: area under the curve 
(AUC),	 sensitivity,	 specificity,	positive	predictive	value	 (PPV)	and	
negative predictive value (NPV). A p value < .05 was considered 
significant.
3  | RESULTS
3.1 | Correlations between ORP values, seminal 
leucocytes concentration and SDF
Summary statistics of all parameters investigated in this study are 
depicted in Table 1. Table 2 shows the correlations between the 
seminal leucocyte concentration, ORP values and SDF. The semi­
nal leucocyte concentration did not correlate with unadjusted ORP, 
sORP,	motORP,	TMSC-ORP	and	SDF.	On	the	other	hand,	weak	but	
significant positive correlations were found between SDF and ORP 
values.	Unadjusted	ORP,	sORP,	motORP	and	TMSC-ORP	showed	a	
highly significant positive correlation with each other.
Grouping of patients into leucocytospermic/non­leucocyto­
spermic and high/low sORP and subsequent analysis with Fisher's 
exact test did not result in the identification of any significant sub­
groups (p = .58). However, the grouping between leucocytospermic/
nonleucocytospermic and high/low SDF was with rather borderline 
significance (p = .0386). On the other hand, Fisher's exact test for 
high/low sORP and high/low SDF was highly significant (p < .0001; 
Tables S1–S3).
3.2 | ROC curve analysis
Receiver operator characteristic curve analyses to determine if 
leucocytospermia can predict the presence of high sORP values 
(>1.34 mV/106 spermatozoa/ml) or if sORP can predict leucocyto­
spermia were negative, indicating that none of these predictions 
(p	=	 .872	and	p = .286, respectively) are possible (Figures 1a and 2). 
On the other hand, a leucocyte concentration lower than 1.2 × 106/
TA B L E  1   Summary statistics of the main parameters analysed in this study
Variables
All samples (n = 1,068) None leucocytospermia (n = 33) Leucocytospermia (n = 26)
Mean (SD) Median (IQ range) Mean (SD) Median (IQ range) Mean (SD) Median (IQ range)
Age (years) 35.98	(7.78) 35.00 (31.00–40.00) 38.36 (9.93) 36.00 (32.00–43.50) 35.07	(7.86) 35.00 (28.00–40.00)
Volume (ml) 3.24 (3.05) 3.00 (2.00–4.00) 2.47	(1.31) 2.00 (1.50–3.00) 3.06 (1.88) 2.50 (2.00–4.00)
Sperm conc. (count/ml) 33.53	(24.07) 28.00 (15.00–45.00) 24.03	(15.77) 22.00	(11.75–32.00) 32.61 (19.18) 28.00	(17.00–50.00)
Total motility (%) 50.92 (18.39) 55.00 (40.00–62.00) 45.33	(26.97) 40.00	(23.75–60.00) 47.04	(12.32) 46.50 (40.00–55.00)
Progressive motility (%) 11.46 (11.53) 10.00 (0.00–20.00) 10.15 (13.89) 0.00	(0.00–17.50) 8.81 (9.81) 5.00 (0.00–20.00)
Normal morphology (%) 5.182 (8.09) 4.00 (2.00–5.00) 2.91 (3.05) 3.00 (0.00–4.00) 4.77	(5.14) 3.00 (2.00–5.00)
SDF (%) 28.49 (18.36) 24.00 (15.00–35.00) 41.27	(24.90) 37.00	(15.00–65.25) 24.69 (12.65) 21.00	(17.00–31.00)
Unadjusted	ORP	(mV) 54.87	(32.03) 51.40	(37.55–66.90) 63.30 (39.03) 54.80	(39.35–73.32) 52.54 (21.98) 48.20 (38.40–61.30)
sORP (mV/106 
spermatozoa/ml)
2.94 (3.90) 1.76	(1.01–3.47) 4.50 (4.63) 2.82	(1.20–5.77) 2.50 (2.01) 1.72	(0.89–4.09)
motORP (mV/106 motile 
spermatozoa/ml)
11.11 (41.05) 3.48	(1.86–7.84) 14.85 (18.21) 7.45	(3.26–21.05) 6.11	(6.37) 3.45	(1.86–7.73)
TMSC-ORP	(mV/106 
motile spermatozoa)
4.81 (20.20) 1.29 (0.60–3.12) 7.93	(10.29) 3.28 (1.60–10.38) 2.52 (2.55) 1.92	(0.60–2.75)
Leucocytes (×106/ml)   0.39 (0.24) 0.40 (0.20–0.60) 2.51 (1.46) 2.00 (1.50–3.00)
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ml	predicts	a	 low	SDF	rate	(<30%)	with	an	AUC	of	0.657,	a	sensitiv­
ity	of	80.0%,	specificity	of	50.0%,	PPV	of	54.1%	and	NPV	of	77.3%	
(p = .0298; Figure 1b). Vice versa, the ROC analysis shows that SDF 
≥45%	can	significantly	predict	leucocytospermia	with	the	following	pa­
rameters:	AUC:	0.679;	specificity:	45.5%,	sensitivity:	92.3%;	positive	
likelihood	ratio:	1.69;	negative	likelihood	ratio:	0.17;	p = .011 (Figure 2).
Receiver operator characteristic curves were generated for 
motORP	and	TMSC-ORP	to	predict	the	rate	of	leucocytospermia	
(Figure 2). In the first case, leucocytospermia can be predicted 
at a cut­off value of 11.46 mV/106	motile	spermatozoa/ml	(AUC:	
0.666; p = .0195) with a specificity of 42.4%, a sensitivity of 
88.5%,	 a	PPV	of	 54.8%	and	 a	NPV	of	 82.4%.	 For	TMSC-ORP,	 a	
value	equal	to	2.97	mV/106 motile spermatozoa can significantly 
(p	=	.0085)	predict	leucocytospermia	(AUC	=	0.683)	with	a	spec­
ificity of 54.5%, sensitivity of 80.8%, PPV of 58.3% and NPV of 
78.3%.	The	two	ROC	curves	did	not	differ	statistically	(p = .6810).
4  | DISCUSSION
Many	 authors	 suggest	 that	 leucocytospermia	 negatively	 impacts	
semen quality as this condition causes and exponentially increases 
TA B L E  2   Summary correlation table of leucocyte count (n = 59), unadjusted ORP (n = 1,068), sORP (n = 1,068), motORP (n = 1,068), 





















































































Note: Data are reported as correlation coefficient (significance p value).
F I G U R E  1   ROC curve analysis. Leucocytospermic condition was used to predict high values of (a) sORP (>1.34 mV/106 spermatozoa/ml) 
and (b) SDF (>30%)
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the amount of seminal ROS, leading to OS (Aziz et al., 2004; Henkel 
et al., 2005). Recent studies demonstrate sORP as a novel marker 
of	 semen	 quality	 (Agarwal	 et	 al.,	 2018;	 Agarwal	 &	Wang,	 2017).	
However, the impact of leucocytes on the seminal redox status and 
therefore their relationship with the seminal ORP is still unexplored.
In this study, no association between the seminal leucocyte 
concentration and ORP values (unadjusted ORP, sORP, motORP 
and	 TMSC-ORP)	 was	 observed.	 This	 result	 was	 unexpected	 as	
leucocytes are thought to be the main source of ROS production 
in semen and would therefore not only contribute significantly to 
seminal OS, but have also a significant detrimental effect on sperm 
function (Plante et al., 1994). However, it has to be considered that 
ORP provides a global picture of the redox balance in semen, that is 
the sum of all oxidants and antioxidants, unlike normal luminometric 
ROS measurements, which assess only one end of the spectrum, 
the oxidants. ORP considers the interplay of all escalating and di­
minishing factors of OS. Hence, correlating a single parameter such 
as leucocyte concentration, which is responsible for increasing the 
amount	of	oxidants,	with	the	ORP	is	not	reasonable.	Moreover,	the	
actual leucocyte number that can cause harm to spermatozoa may 
be underestimated by determining the leucocyte concentration with 
the Endtz test, as it only identifies peroxidase­positive leucocytes by 
staining the peroxisomes (Shekarriz, Sharma, et al., 1995; Shekarriz, 
Thomas, et al., 1995). In semen, numerous types of leucocytes exist, 
such	 as	 polymorphonuclear	 (PMN)	 leucocytes	 and	 macrophages,	
representing 50%–60% and 20%–30% of all seminal leucocytes, 
respectively	(Plante	et	al.,	1994;	Thomas	et	al.,	1997;	Wolff,	1995).	
In fact, several authors have shown peroxidase­positive leucocytes 
to	 be	 the	major	 source	of	 seminal	ROS	production	 (Aitken,	West,	
&	 Buckingham,	 1994;	 Plante	 et	 al.,	 1994;	Wolff,	 1995).	 However,	
the Endtz test cannot identify inactivated cells or those which have 
already released their peroxisomes, resulting in an underestimation 
of the final leucocytes count. Therefore, other infection/inflamma­
tory markers should be used to investigate their association with 
ORP.
Although the leucocyte concentration did not significantly cor­
relate	with	the	ORP	values,	the	parameters	motORP	and	TMSC-ORP	
were	able	to	predict	leucocytospermia.	Both	ORP	values	are	calcu­
lated considering sperm motility, which is the main parameter to be 
affected	by	OS	(Mahfouz	et	al.,	2010).	Therefore,	it	is	not	surprising	
that they were able to predict leucocytospermic condition. However, 
a limitation of this study is that extracellular and intracellular ROS 
could not be discriminated, with the latter being mainly responsi­
ble for the impairment of sperm motility rather than DNA damage 
(Henkel et al., 2005). In fact, OS affects motility mainly through 
the disturbance of the mitochondrial membrane potential and the 
membrane­associated electron transport chain, responsible for ATP 
production	(Agnihotri	et	al.,	2016;	Wang	et	al.,	2003).	Therefore,	a	
role of spermatozoa­generated ROS cannot be excluded, and it may 
explain the relatively moderate predictive values observed for mot­
ORP	and	TMSC-ORP.




 or the hydroxyl radical—OH). Of 
these, only H2O2 is persistent, can penetrate the sperm plasma 
membrane and hence contribute to an increased intracellular ROS 
concentration. The other ROS, O−
2
 and .OH, cannot penetrate the 
lipid membranes although they contribute to phospholipids per­
oxidation, thereby affecting the sperm functions and morphology. 
According to Henkel et al. (2005) the localisation of ROS modu­
lates their impact on DNA integrity, wherein extracellular ROS 
has	a	comparatively	much	 lesser	effect.	Moreover,	an	association	
between the leucocyte count and the amount of intracellular ROS 
in semen was reported (Henkel et al., 2005). Hence, not only the 
seminal leucocyte count, but also the different ROS generated 
may play a role in affecting sperm functions as well as DNA in­
tegrity.	With	OS	being	a	major	cause	of	SDF,	it	was	not	surprising	
to observe a positive association between ORP values and SDF. 
However, several factors other than OS can affect sperm DNA in­
tegrity	 (Morris,	2002;	Muratori	et	al.,	2015;	Sakkas,	Seli,	Bizzaro,	
Tarozzi,	&	Manicardi,	2003).	This	may	explain	why	we	did	not	ob­
serve any significant association between leucocytospermia and 
SDF, although a leucocyte concentration lower than 1.2 × 106/ml 
was able to predict a low SDF rate of <30%.
In conclusion, our data confirm that all ORP values do not 
correlate with leucocytospermia. The sORP is not able to predict 
leucocytospermia,	 but	 motORP	 and	 TMSC-ORP,	 as	 parameters	
based on sperm motility, may be better predictive factors of such 
condition. Although all of these parameters are indicative of semi­
nal OS, however, ORP values, SDF and leucocytospermia should 
be considered independent parameters for the evaluation of semi­
nal redox status, as they investigate distinct seminal features. In 
order to clarify the impact of leucocytes on sperm functions, dif­
ferent methods of identifying leucocytes than the Endtz test need 
to be employed.
F I G U R E  2   Comparison between ROC curves. The sORP (in 
blue),	motORP	(in	green),	TMSC-ORP	(in	red)	and	SDF%	(in	black)	
variables were used to predict the condition of leucocytospermia
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